Michelson Diagnostics

Michelson Diagnostics develops VivoSight, a high-resolution, non-invasive skin imaging system using Optical Coherence Tomography (OCT). It provides rapid 3D visualization of skin lesions, aiding diagnosis and monitoring of skin cancers without biopsies. The technology integrates AI to support clinical decisions and is widely used in clinical and research settings globally.